Registration for a live webinar on 'Chronic inflammation, immune cell trafficking and anti-trafficking agents' is now open.See webinar details
Drug delivery for cancer therapeutics
Published on July 28, 2021 52 min
Other Talks in the Series: Drug Delivery
Nanomedicines for brain diseases
- Prof. Giovanni Tosi
- University of Modena and Reggio Emilia, Italy
This is Professor T. M. Aminabhavi, I'm the Director of Research at the College of Pharmacy, Dharwad, India. I obtained my PhD from the University of Texas in Austin, USA. In the past 35 to 40 years I have been able to publish 800 research papers, and three US patents. I'm presently the editor of The Chemical Engineering Journal. My expertise is in the area of polymer development for drug delivery, membrane science, and wastewater treatment.
In this talk, I'm going to cover different aspects of polymers. What type of polymers are useful with regards to their drug delivery applications. Mainly for drug delivery applications we need to look at smaller sizes, as small as nanoparticle size. We need to develop these systems using polymers of different kinds, and that will be used in cancer therapy. I will cover, in this talk, drug targeting to cancer cells. We will talk about passive and active targeting. Then I will talk about ligand-receptor interactions. I will cover several biopolymers, that is, naturally-occurring polymers. Most of the polymers that we will be covering are poly(lactide-co-glycolide), polylactide, polycaprolactone, alginates (namely sodium alginate), chitosan, hyaluronic acid, solid lipid nanoparticles, and many other polymers such as micelles, dendrimers, and co-polymers, and so on.